ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3074

The Shared Rheumatoid Arthritis HLA-DRB1 Susceptibility Epitope Shapes the Molecular Orientation of Citrulline and the Autoreactive T Cell Receptor Repertoire

Jurgen van Heemst1, Stephen Scally2, Soi Cheng Law3, Diane van der Woude4, Carol Hitchon5, David B. Robinson6, T. W. J. Huizinga7, Hugh H Reid8, René E. M. Toes7, Hani El-Gabalawy9, Jamie Rossjohn10 and Ranjeny Thomas11, 1Leiden University Medical Center, Leiden, Netherlands, 2Monash University, Melbourne, Australia, 3The University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital, Brisbane, Australia, 4Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 5University of Manitoba, Winnipeg, MB, Canada, 6Arthritis Center, University of Manitoba, Winnipeg, MB, Canada, 7Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 8Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, Monash University, Clayton, Melbourne, Australia, 9University of Manitoba Arthritis Center, Winnipeg, MB, Canada, 10Institute of Infection and Immunity, Cardiff University, School of Medicine, Heath Park, Cardiff, England, 11Translational Research Institute, The University of Queensland Diamantina Institute, Brisbane, Australia

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: anti-citrullinated protein/peptide antibodies (ACPA), autoantigens, human leukocyte antigens (HLA) and rheumatoid arthritis (RA), Native Americans

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: ACR Plenary Session III: Discovery 2015

Session Type: ACR Plenary Session

Session Time: 11:00AM-12:30PM

Background/Purpose:

Large-scale genomic studies have identified many genetic associations with autoimmune diseases, but the precise pathogenetic mechanisms by which the associated genes impact disease susceptibility remain unclear in most cases. Furthermore, interpretations may be skewed by the ethnic mix of the samples. RA is linked to particular HLA-DRB1 alleles. In the current understanding, based largely on studies of Caucasians, alleles associated with ACPA-positive RA share a conserved motif at amino acid positions 11, 13, 71 and 74 of DRβ termed the “shared susceptibility epitope (SE)”. His/Phe13β is associated with ACPA-positive RA, while His13βSer polymorphisms are associated with ACPA-negative RA and RA-protection. Indigenous North American (INA) RA patients have a high prevalence of ACPA. In this population, HLA-DRB1*04:04 and 14:02 are implicated as risk factors for RA. While HLA-DRB1*04:04 has a typical SE His/Phe13β, HLA-DRB1*14:02 unexpectedly has a His13βSer polymorphism. Therefore, we aimed to determine the molecular mechanism explaining the association of HLA-DRB1*14:02with ACPA+ RA in INA.

Methods: Competitive HLA-DR binding assays compared citrullinated and native vimentin peptide binding against HA(305-319) indicator peptide. HLA-DRB1*14:02 molecules with their class II-associated invariant peptide (CLIP) were expressed and purified, then loaded with Vimentin-64Arg(59-71) or Vimentin-64Cit(59-71), and the structure was solved using x-ray crystallography. Single CD4+ T cells were sorted from peripheral blood mononuclear cells (PBMC) of 5 HLA-DRB1*1402+ ACPA+ RA patients and 5 of their HLA-DRB1*1402+ ACPA+ non-RA first-degree relatives, based on staining with fluorescent vimentin-64Cit(59-71)-specific and vimentin(59-71)-specific pHLA tetramers. Paired TCRα/β chains were analyzed using multiplex, nested PCR and sequencing.

Results: In binding studies, HLA-DRB1*14:02 displayed no preference for citrulline residues in the P4 pocket. Structures of HLA-DRB1*14:02 complexed with Vimentin-64Arg(59-71) or Vimentin-64Cit(59-71) showed that both citrulline and arginine were accommodated in the P4-pocket of HLA-DRB1*14:02, in contrast to HLA-DRB1*0401/0404 where citrulline but not arginine was accommodated within the electro-positive P4-pocket. When bound to HLA-DRB1*04:01/04 or HLA-DRB1*14:02, citrulline was upright and TCR-exposed. In contrast, arginine was buried in the P4 pocket of HLA-DRB1*14:02. T cell receptor repertoires of citrullinated and native vimentin-sorted CD4+ T cells were distinct among PBMC of HLA-DRB1*14:02+ ACPA+ RA patients and relatives.

Conclusion:

Together, these findings based on SE alleles prevalent among Caucasians and INA suggest a new model for the HLA-DRB1 association with ACPA+ RA, in which the SE shapes the molecular orientation of citrulline and thus the autoreactive citrulline-specific TCR repertoire required for the development of ACPA.


Disclosure: J. van Heemst, None; S. Scally, None; S. C. Law, None; D. van der Woude, None; C. Hitchon, None; D. B. Robinson, None; T. W. J. Huizinga, None; H. H. Reid, None; R. E. M. Toes, None; H. El-Gabalawy, None; J. Rossjohn, None; R. Thomas, None.

To cite this abstract in AMA style:

van Heemst J, Scally S, Law SC, van der Woude D, Hitchon C, Robinson DB, Huizinga TWJ, Reid HH, Toes REM, El-Gabalawy H, Rossjohn J, Thomas R. The Shared Rheumatoid Arthritis HLA-DRB1 Susceptibility Epitope Shapes the Molecular Orientation of Citrulline and the Autoreactive T Cell Receptor Repertoire [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/the-shared-rheumatoid-arthritis-hla-drb1-susceptibility-epitope-shapes-the-molecular-orientation-of-citrulline-and-the-autoreactive-t-cell-receptor-repertoire/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-shared-rheumatoid-arthritis-hla-drb1-susceptibility-epitope-shapes-the-molecular-orientation-of-citrulline-and-the-autoreactive-t-cell-receptor-repertoire/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology